Article

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population

2020-08-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> New commercially available point-of-care (POC) immunodiagnostic tests are appearing, which may yield rapid results for anti-SARS-CoV-2 antibodies. The aim of this study was to evaluate the diagnostic accuracy of rapid antibody detection tests compared to a validated laboratory-based enzyme-linked immunosorbent assay (ELISA) and to investigate infections amongst...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8be57a88-7dc3-5d00-afcf-c645c9d3c66c
DOI: 10.21203/rs.3.rs-50887/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationDOI 10.21203/rs.3.rs-50887/v1Read

Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity Read

Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunitySemantic proximity Read

A comparative review of immunoassays for COVID-19 detectionSemantic proximity Read

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read

Evaluating the adequacy of Prima Covid-19 IgG/IgM Rapid Test for the assessment of exposure to SARS-CoV-2 virusSemantic proximity Read

Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise shipSemantic proximity Read

Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patientsSemantic proximity Read

Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patientsSemantic proximity Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratorySemantic proximity Read

Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteersSemantic proximity Read